Diversity & Inclusion

Strategies for Reducing Health Disparities

A major goal of public health is to reduce health disparities. The programs described in the MMWR Supplement, Strategies for Reducing Health Disparities—Selected CDC-Sponsored Interventions, United States, 2016, are examples of CDC-sponsored initiatives that address health disparities with the goal of advancing health equity.


ASCO Report Outlines Progress Made Toward Reducing Cancer Disparities For LGBTQ+ Individuals

In a new report, ASCO highlighted progress that has been made toward reducing disparities in cancer health among sexual and gender minority (SGM) individuals, although they stressed that additional progress is still needed in this area. The report, which was published in JCO Oncology Practice, served as an update on ASCO’s 2017 position statement “Strategies…

Cleveland Clinic of Florida

S1826 clinical trial for advanced Hodgkin lymphoma

Accrual of the S1826 clinical trial for advanced Hodgkin lymphoma will likely shift treatment modality. Remarkable was the diversity reported for the collaborative study for the first time of the adult and pediatric cooperative research groups.It was the largest Hodgkin lymphoma trial conducted by the National Clinical Trials Network (NCTN) with a highly representative group:…


Genentech: Diversity & Inclusion

We firmly believe that embracing diversity and inclusion (D&I) drives innovation, improves scientific and clinical outcomes, and contributes to equitable healthcare access for all. Here at Genentech, that means fostering belonging within our own walls, advancing inclusive research and health equity in our industry at-large, and transforming society through partnerships across healthcare, education and within all communities. Please learn more HERE.


CancerCoachLive Offers Webinars On Health Equity

CancerCoachLive partners with leading clinical specialists and advocacy organizations to bring free online education to cancer patients and caregivers. CancerCoachLive’s programs are broadcast live through our virtual learning channel, including a panel of experts, interactive Q&A, polling and slides for an immersive learning experience. All of their programmings are available on demand following the live…

JCO Oncology Practice

Toward Achieving Equity in Cancer Clinical Trials

“Racial and ethnic minorities who are traditionally underrepresented in clinical trials have also had worse clinical outcomes over time. Black patients, for example, have a clinical trial enrollment rate of 4%-6% despite representing 15% of the population and have the highest overall cancer death rate. It has been established that numerous barriers to clinical trial participation exist at…

Health Equity Train the Trainer Program

Health Equity Train the Trainer Program, an award-winning training program that is funded by the Florida Blue Foundation, in partnership with Orlando Health, Moffitt Cancer Center, and United Way Broward is a six-week long program with a 10-hour time commitment. There are two live zoom sessions (5 hours total) and 6 modules (5 hours total)…


2022 Cancer Disparities & Health Equity Summit

Professionals from academia, industry, and the community are coming together with the shared mission of closing health equity gaps and developing and sustaining diversity and inclusion efforts in the health system of Florida. Together they will promote the exchange of novel ideas, discuss the latest findings in the field, and stimulate the development of new research, advocacy, and policy on cancer disparities.


Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery

J Natl Compr Canc Netw. 2022;20(10):1092-1098.e2. Schatz AA, Brooks-Coley K, Harrington E, Murray MS, Carlson RW. Cancer prevention and treatment systems are significantly impacted by interpersonal, organizational, and structural and systemic racism. A wide body of research has found that racial disparities in access to guideline-adherent cancer care are pervasive throughout the United States and…


September is Blood Cancer (Disparity) Awareness month

There is disparity in hematologic malignancies in incidence, outcome, survivorship, and clinical trial access. However, there is progress in health equity in hematologic malignancies.  Attached are few representative publications.  The problem of disparity in hematologic malignancies.  “Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?” published in JCO…


FDA Clinical Trial Diversity Guidance

Per the ASCO Daily Post, the U.S. Food and Drug Administration has issued a draft guidance “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry (fda.gov)” at https://www.regulations.gov. for sponsors developing medical products to include a diversity plan, focusing on racial and ethnic diversity, in…


Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement | Journal of Clinical Oncology

  The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) released two new resources to help research sites increase racial and ethnic equity, diversity, and inclusion (EDI) in cancer clinical trials with publication of an article in The Journal of Clinical Oncology that detailed six overarching recommendations for improving EDI in cancer…


ASCO Special Series: Disparities in Cancer Care for Hispanic-LatinX People

EDITORIALS Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States Bosserman et al. pp. 367–369 Citation | Full Text | PDF (111 KB)  A Global Approach to Cancer Equity in the Hispanic/Latinx Population Green et al. pp. 371–373 Citation | Full Text | PDF (113 KB)  Challenges in Genetic Testing and Treatment Outcomes Among Hispanics With Lung Cancer…


March is Myeloma Awareness Month

Racial disparity in myeloma has been evident in incidence and mortality with a twofold difference. Similarly, earlier age at diagnosis and monoclonal gammopathy are almost double in blacks compared to whites. The encouraging news is that outcomes can be similar if access and appropriate treatment specifically bortezomib and autologous transplant are utilized. There have been…


February is Black History Month

February is Black History Month started in 1926 conceived by historian Carter G Woodson  to honor African Americans and raise awareness of Black history.  Although many come to mind to honor, we highlight some pioneers to bring recognition.  Jane C Wright  was a pioneering cancer researcher and  the only woman among seven physicians who helped…


January is Cervical Cancer Awareness Month

January is cervical cancer awareness month. Because of social determinants that affect access to screening,  HPV vaccinations and treatment,  there is disparity in  outcome in cervical cancer in Hispanic women. Cervical cancer incidence and mortality among Hispanic women are about 30%-40% higher than those among non Hispanic White women. The American Cancer Society updated  Cancer Facts & Figures for Hispanic/Latino People 2021-2023 in…


Disparities in Cancer Care and Health Equity Summit 2021

FLASCO is bringing together leaders in cancer disparities and health equity to advance the understanding of and promote their elimination. Cancer disparities represent a major public health problem in our state, and across the country. Professionals from academic, industry, and the community are coming together, with the shared mission of closing health equity gaps, and…


ASCO-ACCC Initiative to Increase Racial and Ethnic Diversity in Clinical Trials

The American Society of Clinical Oncology (ASCO) and the Association for Community Cancer Centers (ACCC) joined forces to ensure that cancer treatment trials better reflect the diversity of cancer populations. The collaboration is led by a Steering Group co-chaired by ASCO President, Lori J. Pierce, MD, FASTRO, FASCO, and ACCC Immediate Past President Randall A….

Conquer Cancer

Gateway Discovery Grant to Address Disparities in Clinical Trials

Gateway for Cancer Research℠ is investing up to $1.5 million to create a more diverse oncology workforce and expand clinical trial access for patients from underserved and minority communities. The Gateway Discovery Grant, administered by Conquer Cancer®, the ASCO Foundation, will provide funding to catalyze innovative clinical research with a strong potential impact on mitigating health…

Now Available: Special session on race and science from the ASH annual meeting

Now Available: Special session on race and science from the ASH annual meeting

This session was developed to raise awareness about systemic racism in research and ensure that the field of hematology is positioned to conduct high-level, cutting-edge science driven by a diverse community. Dr. Mast opens this full-length recording of the session with a moving introduction that touches on his own personal experience coming to grips with bias as a White parent…

© 2021 FLASCO | Premium Website Design by The HDG